Author:
Sigle August,Gratzke Christian,Grabbert Markus
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Huggins C, Hodges CV (1972) Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 22(4):232–240
2. Fachinformation Zytiga. https://www.ema.europa.eu/en/documents/product-information/zytiga-epar-product-information_de.pdf. Zugriffsdatum: 23.04.2023
3. Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY et al (2019) Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial. Lancet Oncol 20(5):686–700
4. Fachinformation Erleada. https://www.ema.europa.eu/en/documents/product-information/erleada-epar-product-information_de.pdf. Zugriffsdatum: 23.04.2023
5. Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S et al (2020) Nonmetastatic, castration-resistant prostate cancer and survival with darolutamide. N Engl J Med 383(11):1040–1049